Search form
Search
Login
Subscribe
Home
Country Intelligence
Industry Directory
Offsets / IC
Tenders
Haiti
(0/week)
Guyana
(0/week)
Honduras
(0/week)
Jamaica
(0/week)
Netherlands Antilles
(0/week)
View all
(0/week)
News
United States
(1365/week)
Manufacturing
(686/week)
Energy
(561/week)
Technology
(1213/week)
Other Manufacturing
(493/week)
Events
About us
Who we are
Our People
Partners
Contact us
LinkedIn
Login
Twitter
Register
Home
News
Skyhawk Therapeutics
Dec 09, 2024
Skyhawk Therapeutics Receives Australian Regulatory Approval to Extend SKY-0515 Treatment Duration in Phase 1 Huntington's Disease Patient Trial
Nov 21, 2024
Skyhawk Therapeutics to Present Preclinical Data of SKY-1214 Combination Treatment in Hematologic Cancers at the 66th American Society of Hematology Annual Meeting
Oct 24, 2024
Skyhawk Therapeutics Presents Compelling Preclinical Data on SKY-1214 at the EORTC-NCI-AACR Molecular Targets and Cancer Therapeutics Symposium
Oct 16, 2024
Skyhawk Therapeutics to Present Preclinical Data on SKY-1214 at the EORTC-NCI-AACR Molecular Targets and Cancer Therapeutics Symposium
Sep 11, 2024
Skyhawk Therapeutics to Present Additional Positive Topline Data from Parts A and B of Phase 1 Clinical Trial of SKY-0515 at European Huntington's Disease Network and Enroll-HD 2024
Feb 28, 2024
Skyhawk Therapeutics Has Advanced to the Multiple Ascending Dose Portion of its Phase 1 Study evaluating SKY-0515, a RNA-Targeting Small Molecule for Huntington's Disease
Dec 22, 2020
Filmmaker Bill Haney Wins Gold Medal From World's Leading Journal Of Scientific Research For Jim Allison: Breakthrough
May 12, 2020
Skyhawk Therapeutics Announces Expansion of its Collaboration Agreement with Merck to Discover and Develop Novel Small Molecules that Modulate RNA Splicing
Nov 12, 2019
Skyhawk Therapeutics Announces a Second Multi-Target Collaboration Agreement with Celgene to Discover and Develop Novel Small Molecules that Modulate RNA Splicing
Sep 04, 2019
RNA Expert Dr. Phillip Sharp Joins as Advisor to Skyhawk Therapeutics
Jul 08, 2019
Skyhawk Therapeutics Announces Collaboration Agreement with Merck to Discover and Develop Novel Small Molecules that Modulate RNA Splicing
Jul 08, 2019
Skyhawk Therapeutics Announces Addition of World Leading SAB Head & New VP of Oncology Biology
Feb 12, 2019
Pioneer in Taking RNA Therpeutics Through the Clinic Joins Skyhawk Therapeutics as Chief Medical Officer
Jan 04, 2019
Biogen and Skyhawk Therapeutics Announce Agreement to Develop Novel Small Molecule RNA Splicing Modifiers for Neurological Disease Targets
Jun 26, 2018
Skyhawk Therapeutics Announces $40 Million Equity Investment Round
Jun 26, 2018
Skyhawk Therapeutics Announces Strategic Collaboration with Celgene to Discover and Develop Novel mRNA Splicing Modifiers using Skyhawk's STAR* Technology Platform
Latest News
Aug 9, 2025
Pack4 Expands Caribbean Operations with Second Facility in Puerto Rico
Aug 9, 2025
Westlake Corporation Declares Quarterly Dividend
Aug 9, 2025
DDB Technology Redefines Innovation by Transforming Business Models, Not Just Products
Aug 9, 2025
NATO says Armenia-Azerbaijan peace deal a 'significant step forward'
Aug 9, 2025
Armenian PM hails peace deal with Azerbaijan
Aug 9, 2025
EU welcomes Armenia-Azerbaijan peace deal
Aug 9, 2025
RoboSense Showcases Active Camera at WRC 2025, Defining the "The Real Eye of Robots"
Aug 9, 2025
Colombian president initiates dialogue with top cocaine gang
View all News
Agenda
30
September
Portugal
Troia, Portugal
Seabed Security, 30 September - 01 October 2025, Troia, Portugal
Seabed Security | 30 September - 01 October 2025 | Troia, Portugal Defence iQ Announces Inaugural Seabed Security...
23
September
United Kingdom
London, UK
Countering Explosive Threat & Demining conference, September 23 - 24, 2025, London, UK
Countering Explosive Threat & Demining conference | September 23 - 24, 2025 | London, UK The Countering Explosive...
View All Events